|
Video: What is a Stock Split?
|
|
Vallon Pharmaceuticals is a clinical-stage biopharmaceutical company primarily focused on the development and commercialization of biopharmaceutical products. Co. is developing medications for central nervous system disorders with a focus on abuse-deterrent medications. Co.'s primary investigational product candidate, ADAIR, is a proprietary, abuse-deterrent oral formulation of immediate-release dextroamphetamine (the main active ingredient in Adderall®) for the treatment of attention-deficit/hyperactivity disorder and narcolepsy. ADAIR is designed to deter attempts to crush and snort and to provide barriers to injection while still providing the therapeutic benefit when taken orally. According to our VLON stock split history records, VLON has had 0 splits. | |
|
VLON (VLON) has 0 splits in our VLON stock split history database.
Looking at the VLON stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into VLON shares, starting with a $10,000 purchase of VLON, presented on a split-history-adjusted basis factoring in the complete VLON stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
02/11/2021 |
|
End date: |
04/21/2023 |
|
Start price/share: |
$7.60 |
|
End price/share: |
$0.40 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-94.74% |
|
Average Annual Total Return: |
-73.99% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$526.41 |
|
Years: |
2.19 |
|
|
|
|
|